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Abstract The Schizosaccharomyces pombe UDP-galactose
transporter cDNA (SpUGT cDNA), encoding the product of
the gms1+ gene which consists of two exon sequences separated
by a 173-bp intron, was cloned by RT-PCR. Its product, a
hydrophobic protein of 353 amino acid residues resembling its
human counterpart, was expressed in the Golgi membranes of
UDP-galactose transporter-deficient Lec8 cells, and comple-
mented the genetic defect of the mutant cells. This indicated that
SpUGT cDNA encodes the functional S. pombe UDP-galactose
transporter. The product of an ORF found in the second exon,
which was previously assumed to be the S. pombe UDP-galactose
transporter, thus represents an inactive, truncated form of the
SpUGT protein.
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1. Introduction
Nucleotide-sugar transporters are localized in the mem-
branes of the Golgi apparatus, and provide various glycosyl
transferases in the Golgi lumen with appropriate substrates
for their reactions (for recent reviews see [1,2]). Recently, sev-
eral nucleotide-sugar transporter cDNAs have been cloned.
These include the human UDP-galactose (UDP-Gal) trans-
porter [3,4], the human, murine and hamster CMP-sialic
acid transporters [4^6], the human, canine and yeast UDP-
N-acetylglucosamine transporters [7^9], and the yeast and
protozoan GDP-mannose transporters [10,11]. These cDNAs
encode highly hydrophobic proteins with multiple putative
transmembrane helices. Several of these were in fact shown
to be expressed in the Golgi membranes, where they were
active in transporting speci¢c substrates [7,10^14].
Recently, the gms1 gene of Schizosaccharomyces pombe
has been reported to be the ¢ssion yeast UDP-Gal transporter
gene, and a 1.4-kbp DNA fragment containing an open read-
ing frame (ORF) encoding a putative membrane protein has
been presumed to de¢ne the coding region of the ¢ssion yeast
UDP-Gal transporter [15]. Its expected amino acid sequence is
in fact similar to that of the human UDP-Gal transporter
(hUGT) throughout the overlapping region. However, the
predicted protein is considerably shorter than the hUGT pro-
tein, and lacks the characteristic N-terminal portion of
hUGT, which contains putative transmembrane helix 1
(TM1) located next to the N-terminal loop. Moreover, the
minimal DNA fragment covering the entire ORF did not
correct the genetic defect of the gms1 mutant, although longer
DNA fragments did [15]. This led us to presume that a miss-
ing exon might be present in the S. pombe genome upstream
of that ORF.
In this report, we describe the isolation and characterization
of a cDNA encoding the functional S. pombe UDP-Gal trans-
porter (SpUGT), that is gms1p. In this cDNA, an hUGT-
TM1-homologous stretch located some 200 bp upstream of
the afore-mentioned ORF, which is designated below
SpUGT(vTM1) ORF, was joined in-frame to it to form a
longer ORF. Upon introduction into UDP-Gal transporter-
de¢cient CHO Lec8 cells, the SpUGT cDNA, but not the
SpUGT(vTM1) cDNA, corrected the mutant phenotype.
2. Materials and methods
2.1. Strains and cell culture
S. pombe strain TY741 (h3 ade6-M216 leu1 ure4-D18) was obtained
from Dr. M. Yamamoto (University of Tokyo, Japan) and grown in
YPD medium. Lec8 (ATCC CRL1737) was maintained in minimum
essential medium K (Life Technologies, Gaithersburg, MD, USA)
supplemented with 10% fetal calf serum.
2.2. Antibodies and Gri¡onia simplicifolia lectin II (GS-II)
These were purchased from the following sources: polyclonal rabbit
anti-HA antibody, Medical and Biological Laboratories, Nagoya, Ja-
pan; rat anti-HA monoclonal antibody (3F10), Roche Diagnostics,
Basel, Switzerland; horseradish peroxidase-conjugated anti-rat IgG,
Santa Cruz Biotechnology, Santa Cruz, CA, USA; £uorescein isothio-
cyanate (FITC)-conjugated goat anti-rabbit IgG, ICN Pharmaceuti-
cals Inc.-Cappel Products, OH, USA; Alexa 594-conjugated goat
anti-rat IgG, Molecular Probes, Eugene, OR, USA; FITC-conjugated
GS-II, EY laboratories, CA, USA.
2.3. Oligonucleotides
NI412 (5P-GAATTCAGTAATGAGAAAATGGCTGTC) and
NI371 (5P-GGCGGCCGCTTAATGCTTATGATCAACGTCCTT)
were designed as putative S. pombe UDP-Gal transporter upstream
and downstream primers, respectively. NI370 (5P-CCGAATTCAAC-
ATGCCTGGATATGATGATAAAC) was designed as a SpUGT-
(vTM1) ORF upstream primer. An in£uenza virus hemagglutinin
(HA)-tag-containing primer, NI436 (5P-GGCGGCCGCTTAGGC-
GTAGTCAGGGACGTCGTAAGGGTAATGCTTATGATCAAC-
GTCCTT), was used to introduce an HA tag into the SpUGT ORF
and SpUGT(vTM1) ORF products. NI412 and NI370 each contain
an EcoRI restriction site, and NI371 and NI436 each contain a NotI
restriction site (underlined in the nucleotide sequences above).
2.4. RT-PCR
The poly(A) RNA was prepared from transfected Lec8 cells using
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a QuickPrep Micro mRNA puri¢cation kit (Amersham Pharmacia
Biotech). Total RNA was prepared from S. pombe strain TY741 using
Isogen (Nippon Gene, Tokyo, Japan). The RNA was treated with
DNase I prior to use for RT-PCR, which was carried out using a
Titan RT-PCR kit (Roche Diagnostics).
2.5. DNA sequencing
The nucleotide sequences of both strands of PCR products were
determined by the dideoxy chain termination method [16] using a
Thermo Sequenase dye terminator cycle sequencing pre-mix kit II
(Amersham Pharmacia Biotech) with an ABI Prism 377 sequencer
(Perkin-Elmer Applied Biosystems). At least three independent clones
from a PCR product were sequenced in order to exclude errors in-
troduced by PCR.
2.6. Western blot analysis
Western blot analysis was performed as previously described [13].
The HA-tagged proteins were detected with anti-HA monoclonal anti-
body 3F10.
2.7. Lectin staining and indirect immuno£uorescence staining
Cells were transfected with appropriate expression vectors using
LipofectAMINE reagent (Life Technologies), following the manufac-
turer’s instructions. Twenty-four hours after transfection, the cells
were transferred onto a coverslip, grown for another 24 h at 37‡C
under 5% CO2, washed once with phosphate-bu¡ered saline (PBS),
and then ¢xed with 3.7% formaldehyde-sodium phosphate bu¡er at
room temperature for 30 min. The ¢xed cells were washed twice with
PBS, and then permeabilized with PBS-0.1% Triton X-100 at room
temperature for 30 min. The cells were treated with FITC-conjugated-
GS-II (1:50) at 37‡C for 30 min, washed twice with PBS, further
treated with the anti-HA antibody (1:100) at 37‡C for 1 h, and
then washed twice with PBS. Finally, the cells were incubated with
anti-rat IgG-Alexa 594 (1:100) at 37‡C for 1 h, washed twice with
PBS and once with water, and then mounted with Perma£uor (Im-
munotech, Marseille, France). Fluorescence labeling was visualized
under a laser scanning confocal microscope (Carl Zeiss LSM510).
3. Results
3.1. Cloning of S. pombe UDP-Gal transporter cDNA
An ORF found in the gms1 locus, which we call
SpUGT(vTM1) ORF here, was previously proposed to be
the coding region of the S. pombe UDP-Gal transporter
[15]. However, the minimal DNA fragment covering it did
not complement the defect of the gms1 mutant (see Fig. 1A
in [15]). We therefore presumed that the ORF might represent
an N-terminally truncated form of the S. pombe UDP-Gal
transporter. Interestingly, the S. pombe genomic DNA se-
quence determined by Lyne et al. at Sanger Center (Gen-
Bank/EMBL/DDBJ accession number AL022598) suggested
the occurrence of a putative exon upstream of that ORF.
The exon exhibited signi¢cant similarity to the N-terminal
portion of hUGT. Since the nucleotide sequence of the puta-
tive intron between the new exon and the exon containing the
entire SpUGT(vTM1) ORF ful¢lled the GT-AG rule [17], we
tested whether this putative intron could be recognized and
excised in mammalian cells.
A 1.2-kbp fragment was isolated from S. pombe genomic
DNA by PCR using NI412 and NI371. The fragment con-
tained the SpUGT(vTM1) ORF and a 314-bp extension into
its upstream region that include the putative exon and intron
sequences, and was designated the UGT gene fragment. The
Fig. 1. Cloning of S. pombe UDP-Gal transporter. A: Agarose gel electrophoresis of RT-PCR products. RT-PCR was carried out with poly-
(A) RNA prepared from pMKIT-neo-transfected (vector control) (lane 1), or pMKIT-neo-UGT-transfected (lane 2) Lec8 cells, and total
RNA prepared from wild-type S. pombe cells (lane 3) as templates. B: Nucleotide and deduced amino acid sequences of S. pombe UDP-Gal
transporter. DDBJ/EMBL/GenBank accession number of the nucleotide sequence is AB023425. The arrowhead indicates the junction of the
¢rst and the second exons. C: Kyte-Doolittle hydrophobicity plot [21] of S. pombe UDP-Gal transporter. The plot was calculated with a win-
dow size of 12 amino acids.
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expression vector pMKIT-neo-UGT was prepared by insertion
of this fragment, and was introduced into UDP-Gal trans-
porter-de¢cient Lec8 cells. Poly(A) RNA was then prepared
from the transfected cells. We also extracted total RNA from
wild-type S. pombe cells to see if the putative intron between
the two hUGT-homologous sequences was spliced out in the
yeast cells. RT-PCR was carried out using NI412 and NI371
as primers.
As shown in Fig. 1A, speci¢c PCR products were detected
using poly(A) RNA from Lec8 cells transfected with
pMKIT-neo-UGT (lane 2), and total RNA from the wild-
type S. pombe cells (lane 3) as templates. In lane 2, a 1.2-
kbp band (the size corresponding to the unspliced transcript)
was detected. In contrast, RT-PCR products from S. pombe
total RNA gave a 1.0-kbp band (lane 3). The size of this band
was that expected for the product obtained after the excision
of the putative intron. The 1.0-kbp RT-PCR product was
cloned into pMKIT-neo between the EcoRI and NotI sites,
and the nucleotide sequence of the insert was determined. The
sequence shown in Fig. 1B indicates that the putative intron
was precisely spliced out, and the hUGT-homologous up-
stream stretch was joined in-frame to the SpUGT(vTM1)
ORF to form a novel ORF (SpUGT ORF) encoding 353
amino acids. These results indicated that SpUGT ORF was
composed of two exon sequences. The yeast splicing signal
was not recognized in mammalian cells. The protein encoded
by this ORF is very hydrophobic, and has multiple putative
transmembrane domains. Its hydrophobicity pro¢le (Fig. 1C)
is very similar to those of other nucleotide-sugar transporters.
3.2. Expression of S. pombe UDP-Gal transporter in Lec8 cells
We examined whether the products encoded by SpUGT
and SpUGT(vTM1) ORFs were expressed in Lec8 cells. To
facilitate the detection of the products, an HA tag was intro-
duced by PCR at the C-terminal portions of SpUGT and
SpUGT(vTM1) using NI412 and NI436, and NI370 and
NI436 as primers, respectively. These DNA fragments were
inserted into pMKIT-neo expression vector, and introduced
into Lec8 cells.
As shown in Fig. 2A, both the HA-tagged SpUGT(vTM1)
(lane 2) and the HA-tagged SpUGT (lane 3) proteins were
detected in the lysates of transfected Lec8 cells probed with
the anti-HA monoclonal antibody. The apparent molecular
masses of the proteins were 33 and 36 kDa, respectively.
This is consistent with the fact that the SpUGT ORF encodes
a protein that is longer by 39 amino acids than the
SpUGT(vTM1) product. The amount of the SpUGT ORF
product expressed in Lec8 cells was about 5-fold more than
that of the SpUGT(vTM1) ORF product.
The intracellular localization of these proteins and their
ability to complement the UDP-Gal transport de¢ciency of
Lec8 cells were examined in cells transiently expressing the
ORF products. Cells transfected with an appropriate expres-
sion plasmid were doubly labeled with the anti-HA monoclo-
nal antibody and FITC-conjugated GS-II lectin (FITC-GS-
II). Lec8 cells e⁄ciently bind FITC-GS-II, which recognizes
the terminal GlcNAc residues on cell-surface glycoconjugates
(data not shown, cf. [18]). If an HA-tagged, functional UDP-
Gal transporter is expressed in Lec8 cells, the cells will be
labeled with the anti-HA antibody, but not with FITC-GS-
II. On the other hand, if the product of the HA-tagged cDNA
is inactive in UDP-Gal transport, then the transfected cells
will be labeled with both the anti-HA antibody and FITC-
GS-II.
Panels a^c in Fig. 2B show that cells expressing the HA-
tagged SpUGT ORF product, which was localized in the
Golgi region, were not labeled with FITC-GS-II. The e⁄-
ciency of transfection in this experiment was about 50%. On
the other hand, FITC-GS-II was bound to cells expressing the
HA-tagged SpUGT(vTM1) ORF product (Fig. 2B, d and e).
This clearly indicates that the SpUGT ORF product, but not
the SpUGT(vTM1) ORF product, was the functional UDP-
Gal transporter of S. pombe, that is gms1p. The HA-tagged
SpUGT(vTM1) ORF product was di¡usely distributed, sug-
gesting its occurrence in the ER (Fig. 2B, f). About 10% of the
Fig. 2. Expression of S. pombe UDP-Gal transporter in mammalian
cells. A: Western blot analysis. Lec8 cells were transfected with
pMKIT-neo (lane 1), pMKIT-neo-SpUGT(vTM1)-HA (lane 2) or
pMKIT-neo-SpUGT-HA (lane 3). Forty-eight hours after transfec-
tion, the cell lysates were prepared, and Western blot analysis was
carried out. B: Analysis of the SpUGT ORF and SpUGT(vTM1)
ORF products and binding of GS-II to the transfected Lec8 cells.
Lec8 cells were transfected with pMKIT-neo-SpUGT-HA (a^c) or
with pMKIT-neo-SpUGT(vTM1)-HA (d^f). Forty-eight hours after
transfection, cells were examined for the binding of FITC-GS-II (b
and e) and anti-HA monoclonal antibody 3F10 (a and d). The
bound antibody was visualized with Alexa 594-conjugated anti-rat
IgG. The £uorescence images were merged with the phase contrast
images (c and f). The arrowheads in d^f indicate the cells expressing
the HA-tagged SpUGT(vTM1) ORF product. Bar, 50 Wm.
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total population of cells expressed the truncated protein.
These results suggest that the N-terminal portion of SpUGT
is important for its targeting to the Golgi apparatus as well as
for its stability in the cell.
4. Discussion
We have isolated a cDNA clone that encodes the functional
UDP-Gal transporter of S. pombe. In this cDNA clone, the
ORF designated here SpUGT(vTM1) ORF and previously
assumed to encode the transporter, is preceded by an up-
stream sequence joined in-frame to it to form an N-terminal
extension of the coding region. The novel ORF encodes a
hydrophobic protein of 353 amino acid residues that is similar
to the human UDP-Gal transporter. The DNA sequence of
the SpUGT ORF exactly matched the putative ORF in the S.
pombe genome proposed recently by Lyne et al., which was
predicted using the Gene¢nder program in PomBase with the
aid of the Sp3splice program [19] to predict the branch-accept-
or sites.
Both the SpUGT ORF and SpUGT(vTM1) ORF products
were expressed heterologously in UDP-Gal transporter-de¢-
cient Lec8 cells, but only the former was able to complement
the genetic defect of the mutant cells. This clearly indicates
that SpUGT represents the genuine S. pombe UDP-Gal trans-
porter and is, by de¢nition, gms1p. Comparisons of amino
acid sequences between S. pombe and mammalian UDP-Gal
transporters revealed 40% and 43% identity with human [3]
and murine (N. Ishida, unpublished data) UDP-Gal trans-
porters, respectively. The functional implications of this iden-
tity and non-identity remain to be elucidated in future studies.
The quick and convenient procedure for the assessment of the
UGT activity devised in the present study would be useful in
such studies directed toward the understanding of the struc-
tural basis of the UGT function. Mutants with attractive fea-
tures may be selected by this procedure for isolation of stable
transformants, which in turn may be utilized for further bio-
chemical studies using Golgi-enriched membrane vesicles.
Functional expression of mammalian UDP-Gal, UDP-N-
acetylglucosamine and CMP-sialic acid transporters in bud-
ding yeast cells has been reported [7,12,14,20]. We showed
here that the HA-tagged SpUGT protein (gms1p) was suc-
cessfully expressed in Lec8 cells, and was localized in the
Golgi apparatus. To our knowledge, this is the ¢rst example
of correctly targeting a multiple-membrane-spanning yeast
Golgi protein to the mammalian Golgi apparatus. Essential
features specifying the localization of Golgi membrane-trans-
porter proteins are likely common to higher eukaryotes and
yeasts. Systematic alteration of amino acids conserved be-
tween the ¢ssion yeast and mammalian UDP-Gal transporters
will provide information about the molecular basis of the
proper targeting and functioning of the transporter.
SpUGT(vTM1) protein lacks the ¢rst putative transmem-
brane helix of the S. pombe UDP-Gal transporter. It was ex-
pressed in Lec8 cells, but was inactive, and showed an abnor-
mal intracellular distribution. This is consistent with our
preliminary results indicating that the integrity of the trans-
membrane helices is important for the proper targeting of
hUGT protein to the Golgi membranes as well as for its
stability (K. Aoki, unpublished observation). Similarly, a chi-
meric protein in which the N-terminal portion of hUGT was
replaced by the corresponding region of CMP-sialic acid
transporter failed to be targeted to the Golgi apparatus (K.
Aoki et al., manuscript in preparation). Targeting signals and
sorting mechanisms of multiple-membrane-spanning Golgi
proteins have remained quite obscure until now, and must
be di¡erent from those of the type II transmembrane proteins
analyzed so far in considerable detail. Chimeric molecules
between human UDP-Gal transporter and S. pombe UDP-
Gal transporter will serve as useful models for analyzing these
challenging issues.
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